Susan A. Brooks

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2018 · 623 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2019 · 456 citations · Full text

Medicine, Gynecology, Oncology +17

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang et al. · The Lancet · 2019 · 424 citations

Medicine, Oncology, Surgery +17

The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells

Ryan Pink, Priya Samuel, Davide Massa et al. · Gynecologic Oncology · 2015 · 221 citations

Medicine, Molecular Biology, Oncology +14

Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay

Lisa Ayers, Malcolm Kohler, Paul Harrison et al. · Thrombosis Research · 2011 · 193 citations

Life Sciences, Cell Biology, Hematology +8